Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W, Trigg A, Lee SE, Chan RH, Diamant Z, Hopkins C, Howarth P, Lund V, Mayer B, Sousa AR, Yancey S, Tabberer M; SYNAPSE study group. Fokkens W, et al. Among authors: sousa ar. J Patient Rep Outcomes. 2023 Jan 20;7(1):4. doi: 10.1186/s41687-023-00543-5. J Patient Rep Outcomes. 2023. PMID: 36662344 Free PMC article. Clinical Trial.
Evaluating treatment response to mepolizumab in patients with severe CRSwNP.
Hopkins C, Han JK, Lund VJ, Bachert C, Fokkens WJ, Diamant Z, Mullol J, Sousa AR, Smith SG, Yang S, Mayer B, Yancey SW, Chan RH, Lee SE. Hopkins C, et al. Among authors: sousa ar. Rhinology. 2023 Apr 1;61(2):108-117. doi: 10.4193/Rhin22.200. Rhinology. 2023. PMID: 36716382 Clinical Trial.
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.
Desrosiers M, Diamant Z, Castelnuovo P, Hellings PW, Han JK, Peters AT, Silver J, Smith SG, Fuller A, Sousa AR, Chan RH, Gevaert P; SYNAPSE study investigators. Desrosiers M, et al. Among authors: sousa ar. Int Forum Allergy Rhinol. 2024 Jan;14(1):18-31. doi: 10.1002/alr.23219. Epub 2023 Jul 18. Int Forum Allergy Rhinol. 2024. PMID: 37345861 Clinical Trial.
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps.
Chupp G, Alobid I, Lugogo NL, Kariyawasam HH, Bourdin A, Chaker AM, Smith SG, Sousa AR, Mayer B, Chan RH, Matucci A. Chupp G, et al. Among authors: sousa ar. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3504-3512.e2. doi: 10.1016/j.jaip.2023.08.015. Epub 2023 Aug 14. J Allergy Clin Immunol Pract. 2023. PMID: 37586475 Free article. Clinical Trial.
Shape-Versatile Fixed Cellular Materials for Multiple Target Immunomodulation.
Sousa AR, Cunha AF, Santos-Coquillat A, Estrada BH, Spiller KL, Barão M, Rodrigues AF, Simões S, Vilaça A, Ferreira L, Oliveira MB, Mano JF. Sousa AR, et al. Adv Mater. 2024 May 13:e2405367. doi: 10.1002/adma.202405367. Online ahead of print. Adv Mater. 2024. PMID: 38739450
Diagnostic performance of the bioline dengue duo rapid test on symptomatic patients assisted at Armed Forces Hospital (Hfa) in Brasília, Brazil.
Gomes LF, Mundim JV, do Carmo Silva L, de Curcio JS, de Sousa ARV, Garcia-Zapata MT, Anunciação CE, do Carmo JR, de Paula Silveira-Lacerda E. Gomes LF, et al. Among authors: de sousa arv. Braz J Microbiol. 2024 Jun;55(2):1801-1809. doi: 10.1007/s42770-024-01351-9. Epub 2024 May 6. Braz J Microbiol. 2024. PMID: 38709438
225 results